SMITH IAN F
Known title: DirectorCIK: 0001197032
Associated companies
Transaction History
| SLDB | ▲ Buy | Option Exercise | 3,440 | — | 10/2/2026 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 3,440 | — | 7/2/2026 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 3,441 | — | 4/2/2026 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 4,573 | — | 1/6/2026 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 4,573 | — | 10/6/2025 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 4,573 | — | 7/6/2025 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 4,574 | — | 4/6/2025 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 3,255 | — | 1/3/2025 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 3,255 | — | 10/3/2024 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 3,255 | — | 7/3/2024 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 3,256 | — | 4/3/2024 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 15,570 | — | 1/3/2024 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 15,569 | — | 10/3/2023 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 15,570 | — | 7/3/2023 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 15,569 | — | 4/3/2023 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 1,620 | — | 1/3/2023 | View on chart |
| SLDB | ▲ Buy | Grant | 13,172 | — | 12/2/2022 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 24,312 | — | 10/3/2022 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 24,313 | — | 7/3/2022 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 24,313 | — | 4/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
SLDB Featured in After-Market Movers List
Solid Biosciences was included in a Benzinga list of healthcare stocks moving in Friday's after-market session. The stock is currently trading near its 52-week low, with an RSI of 20.5 indicating oversold conditions. Analysts maintain an average price target of $18.62, which is significantly higher than the current trading range.
SLDB Featured in After-Market Movers List. Solid Biosciences was included in a Benzinga list of healthcare stocks moving in Friday's after-market session. The stock is currently trading near its 52-week low, with an RSI of 20.5 indicating oversold conditions. Analysts maintain an average price target of $18.62, which is significantly higher than the current trading range.